Michael Pearson, chairman of the board and chief executive officer of Valeant Pharmaceuticals: His methods  proved he didn’t have much patience for research and development. Photograph: Christinne Muschi/Reuters

Valeant Pharmaceuticals is a sleazy company. Although it existed before 2010, it did a deal that year that put it on the map. The deal was with Biovai(...)

Jack Ma: Alibaba boss caused a stir. Photograph: Reuters

Watching the number of scooters and flat-bed tricycles whizzing around the streets of Beijing bearing goods from Alibaba’s various ecommerce units, th(...)

The prospect of a Blackberry takeover begs the question: why? The crisis-hit smartphone company has agreed a tentative $4.7 billion (€3.5 billion) dea(...)